Extramural Discovery Science Accelerator Award Grant

The Extramural Discovery Science Accelerator Award supports the commercialization of ongoing cancer research projects, focusing on experiments that facilitate technology validation and de-risking. Applications are accepted on a rolling basis, with a budget of up to $75,000 for one year. This award encourages independent investigators at any career stage to advance their technologies, with a strong emphasis on commercial viability and collaboration within a learning community.

NOTE:
Applications will be accepted on a rolling basis during the year. Applications submitted through June 1, will be reviewed in July. Applications submitted after June 1, will be reviewed in December.
The intent of the Extramural Discovery Science (EDS) Accelerator Award is to support the commercialization of an ongoing cancer research project and to validate and de-risk technologies. Proposals should address key experiment(s) required to move findings toward commercialization that do not easily fit into traditional grant funding mechanisms. This mechanism is not designed to initiate new projects or develop new directions for an ongoing project. The proposal should be commercially driven with the PI having a plan to license the technology, either to an established company or a start-up if the experiment(s) are successful.
Examples of research that align with the focus of this funding initiative include but are not limited to:

• Dosing, toxicity and/or efficacy testing
• Testing of biopsies or other patient samples to correlate clinical outcome
• Technologies for healthcare delivery

Accelerator awardees will become part of an entrepreneurial collaborative learning community focused on technology commercialization. Grantees will have access to both educational programming developed by the ACS BrightEdge team and the team itself.
Funding
Budgets can be up to $75,000 total costs for a one-year term. Indirect costs are not allowed.

Eligibility

Starting in 2025, applicants must:Be an independent investigator with a full-time faculty appointment (or equivalent), at an eligible US institution. Applicants may be at any career stage.Be motivated to commercialize their technology.